Sanofi SNY Cash Flow Statement (2009-2026)

NASDAQ SNY
$42.79 -0.06 (-0.13%)
As of: Sep 10, 2026 · 1:29 PM EDT
Reported Financials

Sanofi Quarterly Cash Flow Statement

Periods 70 quarters
Latest Jun 2026

Sanofi reported cash from operations of $3.44B and free cash flow of $3.44B for the quarter ended Jun 2026, up 107.9% year over year. This cash flow statement covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
4.40B12.19B3.17B1.84B3.51B9.19B3.49B2.68B4.61B9.67B2.05B2.50B5.11B2.97B3.41B5.27B14.64B-7.16B3.28B2.16B
Deferred Taxes
-0.41B-0.59B-1.33B-0.86B-2.84B
Cash from Discontinued OperationsCash from Discont. Ops
10.74B9.98B0.15B0.05B0.19B0.00B0.22B-4.55B
Gains from Sales and DivestituresGains Divest
-0.34B-0.73B-0.39B-0.39B-0.41B
Gains from Investment SecuritiesGains Investment
0.01B-0.00B0.00B-0.02B0.03B0.02B-0.02B-0.01B-0.00B-0.10B0.02B-0.09B-0.01B-0.10B-0.01B-0.06B-0.14B-0.12B0.04B-0.08B
Asset Writedowns and ImpairmentWritedown
Cash from Restructuring
Non-cash ItemsNon-Cash Items
Change in Working CapitalChange Working Cap.
-0.96B
Change in ReceivablesChange Receivables
-0.79B-0.51B-0.03B-1.40B
Change in InventoryChange Inventory
-0.41B-0.95B-0.93B-0.51B-0.05B
Change in Accured ExpensesChange Accured Exp.
-0.04B-0.12B
Other Working Capital ChangesOther WC Changes
-0.08B-0.53B0.45B-1.13B-0.67B0.45B-1.59B-0.24B-1.86B1.83B-2.52B-0.04B-0.10B0.07B0.20B-0.09B-0.41B0.37B
Cash from OperationsCash from Ops.
3.17B1.07B9.00B2.95B0.89B5.53B1.74B0.10B1.44B8.09B0.32B2.20B1.65B8.54B3.22B1.97B3.44B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
1.68B0.41B1.62B0.40B1.62B0.36B-1.87B-0.42B-2.07B-0.63B
Investing Activities
Capital ExpendituresCapex
-2.34B-2.25B-3.13B-3.41B-4.12B
Sales of Property, Plant and EquipmentPP&E (Sale)
0.39B0.21B0.76B0.44B0.19B0.26B0.85B0.47B0.09B0.16B0.86B0.36B0.10B0.11B0.37B0.13B0.36B
Change in IntangiblesChange Intangibless
0.10B
Acquisitions
-3.39B-0.09B-2.68B-12.79B-1.99B
Divestments
-6.40B-1.01B-2.73B-0.01B-2.02B-2.03B-0.01B-0.60B-0.04B-10.94B
Cash from Investing ActivitiesCash from Investing
-8.35B-2.12B-6.67B-0.40B-3.27B-4.71B-0.82B10.76B-0.37B-2.85B-2.67B-0.42B
Financing Activities
Other financing activitiesOther financing
-0.00B-0.01B-0.01B-0.05B-0.06B-0.06B
Cash from Financing ActivitiesCash from Financing
-8.07B-5.94B-8.66B0.83B-0.72B-6.16B-0.62B-4.41B-6.59B-9.55B-1.79B-2.10B
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
-4.59B-4.25B-4.80B-4.79B-5.14B-5.03B0.09B5.31B-11.16B-5.55B-0.37B6.09B
Additional items
Exchange Rate EffectFX Effect
-0.03B-0.01B-0.01B-0.01B-0.02B-0.02B-0.06B-0.05B0.01B0.01B
Change in Cash
-4.37B1.92B-5.23B6.06B1.65B-6.84B10.59B-4.33B0.51B-2.57B6.36B-1.36B0.58B8.34B1.71B-6.09B-2.47B0.93B
Beginning Cash Balance
15.92B11.20B10.78B10.30B6.91B13.87B7.01B13.70B8.47B9.38B8.56B9.31B7.83B8.42B8.70B8.66B8.96B8.91B
Free Cash FlowFCF
2.34B3.17B1.07B11.25B2.95B0.89B5.53B4.86B0.10B1.44B8.09B3.73B2.20B1.65B8.54B7.34B1.97B3.44B
Net Cash FlowNCF
-16.42B3.17B1.07B0.94B2.95B0.89B5.53B-13.60B0.52B-2.56B8.09B-10.55B0.76B8.00B1.58B-9.18B-2.48B0.92B